{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:26:59Z","timestamp":1790260019415,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"crossref","award":["0350352N"],"award-info":[{"award-number":["0350352N"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIH","award":["P50NS072187"],"award-info":[{"award-number":["P50NS072187"]}]},{"name":"NIH","award":["P50AG16475"],"award-info":[{"award-number":["P50AG16475"]}]},{"name":"NIH","award":["R01 PAS-03-092"],"award-info":[{"award-number":["R01 PAS-03-092"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.parkreldis.2011.06.007","type":"journal-article","created":{"date-parts":[[2011,7,9]],"date-time":"2011-07-09T03:28:30Z","timestamp":1310182110000},"page":"683-688","source":"Crossref","is-referenced-by-count":90,"title":["Cytokine expression and microglial activation in progressive supranuclear palsy"],"prefix":"10.1016","volume":"17","author":[{"given":"Rafael","family":"Fern\u00e1ndez-Botr\u00e1n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeshan","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabi\u00e1n A.","family":"Crespo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandler","family":"Gatenbee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis W.","family":"Dickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Litvan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2011.06.007_bib1","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s11910-004-0055-z","article-title":"Update on progressive supranuclear palsy","volume":"4","author":"Litvan","year":"2004","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.parkreldis.2011.06.007_bib2","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S1474-4422(09)70042-0","article-title":"Progressive supranuclear plasy: clinicopathological concepts and diagnostic challenges","volume":"8","author":"Williams","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.parkreldis.2011.06.007_bib3","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/S0140-6736(99)04137-9","article-title":"Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study","volume":"354","author":"Schrag","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.parkreldis.2011.06.007_bib4","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1212\/WNL.44.11.2015","article-title":"Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy)","volume":"44","author":"Hauw","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2011.06.007_bib5","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/jnen\/60.6.647","article-title":"Microglial activation parallels system degeneration in progressive supranuclear palsy and corticobasal degeneration","volume":"60","author":"Ishizawa","year":"2001","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"key":"10.1016\/j.parkreldis.2011.06.007_bib6","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0896-6273(02)00794-8","article-title":"Inflammation in neurodegenerative disease \u2013 A double-edged sword","volume":"35","author":"Wyss-Coray","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.parkreldis.2011.06.007_bib7","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.2174\/092986707780597961","article-title":"Microglial activation and its implications in the brain diseases","volume":"14","author":"Dheen","year":"2007","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.parkreldis.2011.06.007_bib8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pneurobio.2005.06.004","article-title":"Microglia and inflammation-mediated neuro-degeneration: multiple triggers with a common mechanism","volume":"76","author":"Block","year":"2005","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.parkreldis.2011.06.007_bib9","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nri2565","article-title":"Regulation of innate immune responses in the brain","volume":"9","author":"Rivest","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.parkreldis.2011.06.007_bib10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1750-1326-4-47","article-title":"Does neuroinflammation fan the flame in neurodegenerative diseases?","volume":"4","author":"Frank-Cannon","year":"2009","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.parkreldis.2011.06.007_bib11","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nri1664","article-title":"Interleukin-1 and neuronal injury","volume":"5","author":"Allan","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.parkreldis.2011.06.007_bib12","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0304-3940(94)90746-3","article-title":"Tumor necrosis factor alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients","volume":"165","author":"Mogi","year":"1994","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.parkreldis.2011.06.007_bib13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0304-3940(94)90684-X","article-title":"Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson\u2019s disease","volume":"172","author":"Boka","year":"1994","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.parkreldis.2011.06.007_bib14","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0304-3940(94)90508-8","article-title":"Interleukin-1, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients","volume":"180","author":"Mogi","year":"1994","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.parkreldis.2011.06.007_bib15","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0165-0173(95)00011-9","article-title":"The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases","volume":"21","author":"McGeer","year":"1995","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.parkreldis.2011.06.007_bib16","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/NEN.0b013e31817d7a1d","article-title":"Validation of the neuropathologic criteria of the third consortium for dementia with Lewy bodies for prospectively diagnosed cases","volume":"67","author":"Fujishiro","year":"2008","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"key":"10.1016\/j.parkreldis.2011.06.007_bib17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2199-7-3","article-title":"The RIN: an RNA integrity number for assessing integrity values to RNA measurements","volume":"7","author":"Schroeder","year":"2006","journal-title":"BMC Mol Biol"},{"key":"10.1016\/j.parkreldis.2011.06.007_bib18","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1152\/physiolgenomics.00025.2005","article-title":"GAPDH as a housekeeping gene: analysis of GAPDH mRNA expression in a panel of 72 human tissues","volume":"21","author":"Barber","year":"2005","journal-title":"Physiol Genomics"},{"key":"10.1016\/j.parkreldis.2011.06.007_bib19","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1523\/JNEUROSCI.23-05-01605.2003","article-title":"Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway","volume":"23","author":"Li","year":"2003","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.parkreldis.2011.06.007_bib20","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/1531-8249(200003)47:3<365::AID-ANA13>3.0.CO;2-G","article-title":"Association of interleukin-1 (IL-1) gene polymorphisms with Alzheimer\u2019s disease","volume":"47","author":"Nicoll","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1016\/j.parkreldis.2011.06.007_bib21","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/S0002-9440(10)61105-4","article-title":"Cerebrovascular transforming growth factor-\u03b2 contributes to inflammation in the Alzheimer\u2019s disease brain","volume":"160","author":"Grammas","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.parkreldis.2011.06.007_bib22","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/39321","article-title":"Amyloidogenic role of cytokine TGF-\u03b21 in transgenic mice and in Alzheimer\u2019s disease","volume":"389","author":"Wyss-Coray","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.parkreldis.2011.06.007_bib23","doi-asserted-by":"crossref","first-page":"7015","DOI":"10.4049\/jimmunol.172.11.7015","article-title":"TGF-\u03b21 represses activation and resultant death of microglia via inhibition of phosphatidylinositol 3-kinase activity","volume":"172","author":"Kim","year":"2004","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.parkreldis.2011.06.007_bib24","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nm1781","article-title":"Blocking TGF-beta-Smad2\/3 innate immune signaling mitigates Alzheimer-like pathology","volume":"14","author":"Town","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.parkreldis.2011.06.007_bib25","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0197-4580(98)00089-X","article-title":"TGF-beta receptors-I and \u2013II immunoexpression in Alzheimer\u2019s disease: a comparison with aging and progressive supranuclear palsy","volume":"19","author":"Lippa","year":"1998","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.parkreldis.2011.06.007_bib26","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.4049\/jimmunol.142.12.4295","article-title":"Modulation of cytokine production by transforming growth factor-\u03b2","volume":"142","author":"Chantry","year":"1989","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.parkreldis.2011.06.007_bib27","doi-asserted-by":"crossref","first-page":"23301","DOI":"10.1016\/S0021-9258(18)50091-0","article-title":"Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-\u03b2 and interleukin-10","volume":"267","author":"Bogdan","year":"1992","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.parkreldis.2011.06.007_bib28","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1084\/jem.180.5.1587","article-title":"Transforming growth factor \u03b2: the good, the bad and the ugly","volume":"180","author":"Wahl","year":"1994","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.parkreldis.2011.06.007_bib29","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1097\/nen.0b013e31815c196a","article-title":"Postmortem delay has minimal effect on brain RNA integrity","volume":"66","author":"Ervin","year":"2007","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"key":"10.1016\/j.parkreldis.2011.06.007_bib30","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1212\/WNL.0b013e3181a81664","article-title":"NSAID exposure and risk of Alzheimer\u2019s disease. Is timing everything?","volume":"72","author":"Bennet","year":"2009","journal-title":"Neurology"}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802011001830?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802011001830?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T01:51:41Z","timestamp":1686189101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802011001830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S1353802011001830"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2011.06.007","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}